Antiangiogenesis: a new approach to the treatment of lymphoma.
Ganjoo
Kristen
K
Department of Medicine (Oncology), Stanford University, Palo Alto, CA 94304, USA. kganjoo@stanford.edu
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors